Literature DB >> 24951226

Surgical resection of a malignant liver lesion: what the surgeon wants the radiologist to know.

David S Shin1, Christopher R Ingraham, Manjiri K Dighe, Carolyn Wang, Sandeep Vaidya, Mariam Moshiri, Chandana Lall, James O Park, Puneet Bhargava.   

Abstract

OBJECTIVE: Hepatic malignancy is a common and lethal disease, whether due to a primary tumor or metastasis. There are numerous treatment options available depending on the stage of the disease and medical condition of the patient, including systemic chemotherapy, transcatheter embolization, thermal ablation, and surgical resection. In a subset of patients with liver malignancy, surgical resection can offer the best chance of long-term survival and potentially even cure. This article reviews the major indications and contraindications for resection, basic surgical techniques and terminology, key clinical and imaging preoperative workup, and pertinent interventional oncology procedures in the management of hepatic malignancy.
CONCLUSION: Diagnostic and interventional radiology plays an important role in the assessment and treatment of malignant hepatic lesions. Radiologists should be familiar with how surgeons select, work up, and treat candidates for liver resection to provide the most clinically valuable service.

Entities:  

Keywords:  hepatic malignancy; hepatocellular carcinoma; liver resection; surgical planning

Mesh:

Year:  2014        PMID: 24951226     DOI: 10.2214/AJR.13.11701

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.

Authors:  Daniel I Glazer; Servet Tatli; Paul B Shyn; Mark G Vangel; Kemal Tuncali; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2017-09-27       Impact factor: 3.959

Review 2.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

Review 3.  Syncope as the initial presentation of pulmonary embolism in two patients with hepatocellular carcinoma: Two case reports and literature review.

Authors:  Dayong Deng; Haidi Wu; Huafang Wei; Zikai Song; Yang Yu; Chongyin Zhang; Lei Yang
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

4.  The effects of percutaneous ethanol injection followed by 20-kHz ultrasound and microbubbles on rabbit hepatic tumors.

Authors:  Zhi Yong Shen; Gan Lin Xia; Ming Feng Wu; Lei Yan Ji; Yong Jun Li
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-26       Impact factor: 4.553

Review 5.  Communicating with the hepatobiliary surgeon through structured report.

Authors:  Roberto Cannella; Adele Taibbi; Salvatore Pardo; Giuseppe Lo Re; Ludovico La Grutta; Tommaso Vincenzo Bartolotta
Journal:  BJR Open       Date:  2019-04-29

6.  The role of imaging in surgical planning for liver resection: what the radiologist need to know.

Authors:  Andrea Agostini; Alessandra Borgheresi; Chiara Floridi; Marina Carotti; Giulia Grazzini; Francesco Pagnini; Susanna Guerrini; Pierpaolo Palumbo; Silvia Pradella; Gianpaolo Carrafiello; Marco Vivarelli; Andrea Giovagnoni
Journal:  Acta Biomed       Date:  2020-07-13

Review 7.  State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization.

Authors:  Gustavo Felipe Luersen; Priya Bhosale; Janio Szklaruk
Journal:  J Hepatocell Carcinoma       Date:  2015-07-10

8.  IMHOTEP: cross-professional evaluation of a three-dimensional virtual reality system for interactive surgical operation planning, tumor board discussion and immersive training for complex liver surgery in a head-mounted display.

Authors:  Hannes Götz Kenngott; Micha Pfeiffer; Anas Amin Preukschas; Lisa Bettscheider; Philipp Anthony Wise; Martin Wagner; Stefanie Speidel; Matthias Huber; Felix Nickel; Arianeb Mehrabi; Beat Peter Müller-Stich
Journal:  Surg Endosc       Date:  2021-01-21       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.